Eudaimonia Asset Management »

Castle Biosciences shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 74k 38.90
2020-12-31 $1.8M 26k 67.15
2020-09-30 $3.3M 65k 51.44
2020-06-30 $3.0M 79k 37.68
2020-03-31 $2.7M 90k 29.81
2019-12-31 $2.2M 65k 34.37
2019-09-30 $615k 34k 18.09

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Rtw Investments
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Summit Partners Public Asset Management
State Street Corporation
Geode Capital Management
Palisade Capital Management
AIGH Capital Management
Allianz Asset Management
Millennium Management
Daniel D. Thurber
Nuveen

View all funds holding Castle Biosciences